Randomized, controlled, multi-center phase II study of postoperative enoxaparin treatment for venous thromboembolism prophylaxis in patients undergoing surgery for hepatobiliary-pancreatic malignancies.

Go ShinkeYutaka TakedaYoshiaki OhmuraShogo KobayashiHiroshi WadaOsakuni MorimotoAkira TomokuniJunzo ShimizuTadafumi AsaokaMasahiro TanemuraTakehiro NodaYuichiro DokiHidetoshi Eguchi

Published in: Annals of gastroenterological surgery (2024)

The perioperative administration of enoxaparin in hepatobiliary-pancreatic malignancies is feasible and safe. However, further case accumulation and investigation are necessary to assess its potential in reducing the occurrence of VTE.

Keyphrases

venous thromboembolism
patients undergoing
phase ii study
open label
direct oral anticoagulants
placebo controlled
minimally invasive
double blind
locally advanced
phase iii
phase ii
coronary artery bypass
cardiac surgery
study protocol
rectal cancer